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Background: The evaluation of new long-lasting insecticidal bed nets (LLINs) is coordinated by the WHO Pesticide
Evaluation Scheme (WHOPES). In 2007, Netprotect® was granted WHOPES interim recommendation after Phase I
and II evaluations. Present study evaluates Netprotect® in a Phase III trial in rural Cambodia.
Methods: A randomized, prospective longitudinal study design was used to assess the performance of Netprotect®
over a period of three years, using conventionally-treated nets and a WHOPES recommended LLIN (PermaNet® 2.0)
as positive controls. The primary outcomes were the physical integrity, insecticide content and cone bioassay
performance using.
Results: The baseline deltamethrin concentration of 43% of Netprotect® nets were below the tolerance limit while
27% of PermaNet® 2.0 nets were above the target dose limits. By 36 months Netprotect® retained 35% while
PermaNet® 2.0 retained 49% of baseline insecticide dose. Moreover the proportion of the inactive deltamethrin
R-alpha isomer in the Netprotect® nets was 33% at the baseline and increased to 69% after three years while it was
low and almost constant for PermaNet® 2.0 (3-7%). Only 71% of Netprotect® met the WHO criteria for bio-efficacy
after three years while at least 80% is required. Moreover Netprotect® nets failed for the WHOPES criteria after 12
and 24 months. The reference LLIN met the WHOPES criteria throughout the study. Over the entire three years the
reference LLIN did obtain significant higher mosquito mortality than Netprotect®. The physical integrity was based
on the proportionate hole index and after three years, 25% of Netprotect® and 30% of PermaNet® 2.0 were in a
mediocre or poor state.
Conclusion: Netprotect® did not meet the minimum WHO criteria for bio-efficacy after 12, 24 and 36 months. The
use of a reference LLIN as positive control was helpful for data interpretation. However, for future three-year studies,
it is essential that before initiating any study nets should be checked for their specifications and this for both the
candidate LLIN as well as for the reference LLIN. Moreover, to improve the accuracy of the success rate of the
candidate LLIN more nets should be tested for their bio-efficacy at the end of the trial.* Correspondence: mcoosemans@itg.be
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Over the past decades, insecticide treated nets (ITNs)
have proven to be the key measure in malaria prevention
worldwide [1-3]. This success is mainly related to the
development of long-lasting insecticidal nets (LLINs)
where insecticide is incorporated into or coated onto the
fibres. An LLIN must retain its biological activity after at
least 20 washes and three years of use under field condi-
tions. So far the World Health Organization (WHO) did
not define criteria for net integrity but has invited the na-
tional malaria control programmes to assess the durability
of LLINs in operational conditions [4].
New LLINs are granted a time-limited WHOPES interim
recommendation for use after successful evaluations in lab
conditions (Phase I) and in experimental huts (Phase II),
during which wash-resistance, induced vector mortality
and blood-feeding inhibition is demonstrated. To receive a
full recommendation, prospective studies (Phase III) are
required to demonstrate a bio-efficacy during at least three
years. Physical durability and survivorship of LLINs are
also assessed at this stage.
Currently seven LLINs have received full recommenda-
tion from WHOPES and four have an interim recommen-
dation. Until recently candidate LLINs were compared to
conventionally-treated nets (CTNs). However the inter-
and intra-net variation of the amount of insecticide was
considerable with these CTNs and in 2012 the WHOPES
working group decided to use a reference LLIN as positive
control [5].
The present study evaluates Netprotect®, interim recom-
mended since 2007 [6], in a phase III trial in Cambodia
according to WHO guidelines and procedures applicable
at the onset of the study using a CTN as positive control
[7]. Moreover, a reference LLIN (PermaNet® 2.0) was used
as additional positive control. The performance of the nets
was assessed in terms of efficacy, insecticide content, wash
resistance, longevity, fabric integrity and community




Present study was conducted between 2009 and 2013 in
Veal Veng district, a rural forested area in the province
of Pursat, in Cambodia at the border with Thailand. In
this area, 1.5% malaria prevalence is detected based on
Rapid Diagnostic Tests/microscopy (Cambodia Malaria
Survey 2010) [8]. The main malaria vectors are Anopheles
dirus sensu stricto, Anopheles minimus s.s., Anopheles
maculatus and Anopheles barbirostris. All vectors are fully
susceptible to pyrethroids [9].
In Cambodia, the overall proportion of people sleeping
under an ITN/ LLIN “the previous night” increased the
last years to more than 50%. About 63% of householdsowned sufficient amount of mosquito nets but only 23%
of the 3,164 households (HHs) interviewed during the
Cambodia Malaria Survey (CMS) 2010 [8] owned suf-
ficient LLINs. This net coverage contributed to the
decrease of the overall malaria prevalence in Cambodia
from 4.4% in 2004 [10] and 2.6% in 2007 [11] to 0.9%
in 2010.Study design and sample size
A phase III field trial, designed as a prospective longi-
tudinal study, was set up to study the performance of
Netprotect® using conventionally-treated nets (CTN) as a
positive control. The study protocol followed the WHO
guidelines for phase III LLIN field trials [7] except that a
reference LLIN (PermaNet® 2.0) was used as an additional
positive control. The unit of observation was the house-
hold (HH), in which one net was assigned for follow up.
CTNs and their use were monitored for one year and the
LLINs (Netprotect®, PermaNet® 2.0) for three years.
Seven field surveys were organized for the follow-up
of the nets. A first survey took place one week post-net
distribution and subsequent surveys were conducted
every six months. During each survey a randomized
sample of the three net types was collected and submit-
ted to a physical integrity test and cone bioassay test. In
the latter test, susceptible colony mosquitoes were ex-
posed to the nets and the mosquito knockdown and mor-
tality was recorded (see Bio-efficacy section for details). A
minimum of 510 HHs was necessary enabling sampling
30 nets of all types per survey. To count for nets lost for
follow up, 90 HHs for each LLIN type and 50 HHs for
CTN were added. Therefore, seven villages (with a mini-
mum of 90 HHs per village) were selected in Veal Veng
district to cover a total of 740 HHs.Nets, CTN treatment and distribution
The LLIN Netprotect®, manufactured by Bestnet Europe
LTD, is a LLIN made of polyethylene with deltamethrin
incorporated into the 118-denier monofilament with a
target dose of 1.8 g active ingredient (a.i.)/kg, correspond-
ing to 68 mg a.i./m2 (weight 35 g/m2). The nets dis-
tributed had a standard size of 160 cm W× 180 cm L ×
150 cm H. The PermaNet® 2.0 was bought from Vester-
gaard Frandsen. This is a WHOPES fully recommended
LLIN [12] made of knitted poly-filament polyester fibres
coated with deltamethrin with a target dose of 1.4 g a.i./kg
for a 100 denier yarn, or 55 mg a.i./m2. The PermaNet® 2.0
nets had the same colour (blue) and size as the Netprotect®
nets. The conventionally-treated nets (CTNs) were blue
but slightly wider (190 cmW×180 cm L × 150 cm H) than
both LLINs with a fabric weight of 31.1 g/m2. The delta-
methrin treatment (Deltamethrin EC 10 or 10,0 g a.i./L) of
these nets, as per the standard WHO instructions [13], was
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protective gear, at a target dose of 25 mg a.i./m2.
Prior to the net distribution, a HH census was con-
ducted in the study area to obtain the demographic and
socio-economic characteristics of each HH. The HH
census data were entered in an Access database to form
a master list. From this master list, all HHs in the selected
villages were randomly allocated to one of the three study
arms in a 2:2:1 ratio, for respectively Netprotect®, PermaNet®
2.0 and CTN, and this in each village. For HHs assigned
to Netprotect® or PermaNet® 2.0 nets, enough nets of the
same type were distributed to assure full coverage (i.e. one
net per two inhabitants), but only one of these nets was
assigned as net to follow up. In HHs assigned to CTN, only
one CTN was distributed, and additional Netprotect®
nets were distributed to cover all residents. In December
2009, a total of 148 HHs were provided with a CTN, 305
HHs with Netprotect® nets and 309 HHs with PermaNet®
2.0 nets.
All distributed nets received a unique Net ID number,
written with wash-resistant ink on the factory label. The
net with the highest code number within each HH was
retained for follow up.
Surveys/field procedures
For every sampling round a HH randomization was made
to sample 30 nets of each study arm, evenly distributed
over the villages. As people were not always present dur-
ing the survey or nets were lost, 60 HHs per study arm
were randomized. The HHs were visited according to the
randomization order, until the number of samples were
achieved per village and type of net brand. Nets selected
and withdrawn were replaced with a new LLIN without
ID number. HHs where people were absent (for more
than three consecutive days) were maintained in the mas-
ter list for the next randomization, while the HHs where
the net was sampled were removed from the master list.
In the first year of the study the HHs that recorded loss of
their net for follow up were also removed from the master
list. However, because of the high number of nets lost for
follow up, it was decided after one year that only the HHs
that were sampled or moved away would be removed
from the master list. Nets randomized for the second time
and still lost for follow-up, were recorded as lost and
removed from the master list. From that point on though,
the second highest net ID in that specific HH would
become the new net to follow up for the upcoming
sampling surveys.
During the surveys, HH owners or net users were
interviewed by trained staff about their net use (method
and frequency), washing habits (frequency and method
of washing and drying) and the occurrence of adverse
events. The net to follow up was sampled for submission
to physical integrity tests and cone bioassay tests. Chemicalanalysis were done only on the nets sampled 1 week,
6 months, 12 months and 36 months after net distri-
bution. At the end of the first study year, besides the
normal sampling of the three net types, the remaining
CTNs were collected and replaced with a Netprotect®
or PermaNet® 2.0.
In the annual surveys (at the end of months 12, 24 and
36) in addition to the randomized HHs, all households
remaining in the master list were visited door-to-door.
Whereby the physical presence/absence and the infor-
mation on people’s net perceptions and practices were
recorded, to help estimate the annual attrition rate.Physical inspection of nets
All nets sampled during the surveys were examined for
their physical integrity. The integrity of the nets was
determined counting the number of tears and holes as
described in [14]. Hole sizes were categorized in three
groups; holes allowing a thumb to pass through, holes
between a thumb and a closed fist and holes bigger than a
closed fist. A proportionate hole index (pHI) [15,16] was
calculated by making the sum of the holes weighted by
size for each net. For these groups, the weights used to
calculate the pHI were 1, 9 and 56 as described in [15,16].
To better translate the hole index to an integrity status
(net condition) for each sampled net, the pHI is catego-
rized into good (<25), fair (25–174), mediocre (175–299)
and poor (>299) net condition [16]. The dirtiness of the
nets was determined by comparing the nets to reference
samples (clean, bit dirty, dirty, very dirty and never used).Insecticidal activity
Bio-efficacy
Five samples per net (25 × 25 cm) were cut from the
positions 1 to 5 of the net according to the guidelines [4]
once the physical integrity test was completed. The WHO
cone bioassays, as described in the WHOPES guidelines
[7], were conducted on these samples.
Bioassays were conducted at 27 ± 2°C and 80 ± 10%
relative humidity. The An. dirus s.s. colony used in these
bioassays was fully susceptible to deltamethrin, DDT and
permethrin. Five non-blood-fed, 2–5-day-old An. dirus
females were exposed for three minutes in each cone
and then held for 24 hours with access to a sugar solution.
For each sample two replicates were performed. Knock-
down and mortality were measured 60 minutes and
24 hours after exposure respectively. A negative control,
from an untreated net, was included in each round of
cone bioassay testing. If the mortality in the control, in-
secticide free net, was below 10% for a given day the data
were adjusted with Abbott’s formula [17]. If the mortality
in the control was >10%, all the tests for that day were
repeated.
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were used to assess the base line profile for bio-efficacy of
insecticide. Based on the cone bioassay results at month
36, the LLINs that did not meet the criteria of ≥95%
knockdown or ≥80% mortality were subjected to a tunnel
test to determine the efficacy (mortality and blood feeding
inhibition) as described in the WHOPES guidelines [7].
As the colony of An. dirus is maintained on mice, this host
was preferred to guinea pigs for the tunnel test. Nets
fulfilling the criteria of ≥80% mortality or ≥90% blood-
feeding inhibition in the tunnel test were considered
to be still effective. The tunnel test was valid only if
in the control a threshold of 36% blood-feeding is
reached [14]; however, higher rates such as 50% are more
appropriate [4].
Insecticide content
Nets sampled at 1 week, and 6, 12 and 36 months post-
distribution were chemically analysed to determine their
insecticidal content. This was carried out on four pieces
(25 × 25 cm) per net, similar to the bioassay samples on
positions 2 to 5 of the net. Each sample was individually
packed in aluminum foil and kept at 4°C until further
analysis at the Walloon Agricultural Research Centre
(CRA-W), Gembloux, Belgium (WHO Collaborating Centre
for Quality Control of Pesticides) using an ISO 17025 ac-
credited analytical method.
The four samples from each LLIN/CTN were combined
to provide the average concentration of the insecticide in
each LLIN/CTN. Briefly, deltamethrin was extracted by
heating the sample under reflux for 60 minutes with xy-
lene in presence of dipropyl phthalate as internal standard.
Insecticide content determination was carried out by
using Gas Chromatography with Flame Ionization Detec-
tion (GC-FID).
Results were expressed as g a.i./kg and converted to
mg a.i./m2 using the fabric weight. A tolerance limit
of ± 25% of the target dose is recommended in the
WHO specification [18]. This analytical method was fully
validated for determination of deltamethrin in incor-
porated LLINs and was proved to provide similar results
than those obtained by the standard reference CIPAC
method 333/LLIN/(M2)/3 (HPLC-DAD) published later in
2012 in the CIPAC Handbook N [19].
The content of both the biological active S-alpha isomer
(deltamethrin) [(S)-a-cyano-3-phenoxybenzyl (1R,3R)-3-
(2,2-dibromovinyl)-2,2-dimethylcyclopropane carboxylate)]
and the inactive R-alpha isomer [(R)-a-cyano-3-phenoxy-
benzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopro-
pane carboxylate)] was measured on all samples.
Functional survivorship rate
The CTN and LLIN functional survivorship rates were
calculated from the records made during the surveys atthe end of each study year. The functional net survivor-
ship accounts for loss due to damage only and is not
influenced by nets that are removed from the study area
(stolen, given away or family moved) as they still may be
functional [20].
Data entry and analysis
All data were recorded on standard forms. The hard copy
data was single entered into the main Access database.
Data entry was checked by cross checking all entered re-
cords of adverse events, physical integrity and bioassays
with the hard copy files. All data were imported into R,
version R-3.0.2 [21], for statistical analysis.
Descriptive analyses were done on the demographic
household census data, to define the household character-
istics. Data collected on net use and net washing habits
were analysed using a chi-square test (χ2) for significance
of deviation between the net types.
For the analysis of net performance (physical condition,
chemical content, bioassay) all sampled nets were used
except nets that were still in the original plastic bag
(i.e. never used) and nets that were completely torn and
thrown away.
For each net chemical content and bioassay perform-
ance were calculated from all samples apart from position
1, as the lowest part of the net may be exposed to
excessive abrasion in routine use. For chemical analysis
an inter-net variation was expressed by relative standard
deviation (RSD). For the bioassays, each of the four
samples were tested individually and an assessment
of between-net variability was done with a RSD. The
within-net variability was expressed as the difference of
samples of the same net to the mean expressed as percent
of the mean and then averaged over the sample [15].
A Chi-Square test over multiple strata was conducted
(Mantel Extension Test [22] on the acceptance of the
nets (proportions of LLINs that fulfil the WHO criteria
(≥95% knockdown or ≥80% mortality).
A generalized linear mixed model (GLMM) was fitted
for chemical content, bio-efficacy and net integrity as
response variable. As fixed effect explanatory variables
the net type, survey (time point), net condition, dirtiness
of the net, net use intensity, number of washes, drying
and washing method and socioeconomic status (SES)
were included. The net ID was included as a random ef-
fect. Per outcome the model was optimized by removing
the insignificant variables using a likelihood ratio test [23]
or by comparing the AIC (Akaike information criterion)
values [24].
Ethical clearance
Ethical approval for the study was obtained from the
Ethics Review Committee of WHO for two arms (CTN
and Netprotect®) and from the Ethical Committee of
Table 1 Functional net survivorship rate
Survey Net type N Functional survivorship (95% CI)
Year 1 CTN 45 97. 8 (88.4 – 99.6)
Netprotect® 141 96.5 (91.5 – 98.2)
PermaNet® 2.0 143 98.6 (95–99.8)
Year 2 Netprotect® 67 92.5 (83.7 – 96.8)
PermaNet® 2.0 78 98.7 (93.1 – 99.8)
Year 3 Netprotect® 43 58.1 (43.3 – 71.6)
PermaNet® 2.0 49 61.2 (47.2 – 73.6)
Calculated from all the HHs visited at the end of each study year where the net
was present or discarded because of being torn or burned (Surveys 4, 6 and 8).
HHs where the inhabitants were absent or where the net was recorded as given
away, used elsewhere, stolen or lost were not included in the estimates of
survivorship.
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of Tropical Medicine and the legal ethical committee
of the University of Antwerp for all three arms (CTN,
Netprotect® and PermaNet® 2.0).
An informed consent was signed by impregnators and
by HH owners. All participants were informed about the
benefit of using an insecticide impregnated net and the
additional advantages of using a LLIN. The information
sheet addressed also the possible adverse effects and their
remediation for all users.
Results
Net distribution and household characteristics
The random allocation of each HHs to one of the net
types was in all 7 villages according to a 2:2:1 ratio, for
respectively Netprotect® (305 HH), PermaNet® 2.0 (309
HH) and CTN (148 HH). All HHs together comprised
of 3,832 individuals of which 45% were younger than
17 years and 26% were between 17 and 30 years old.
The average age of the head of the HHs is 42 years, 74%
of them had no education, 23% a primary education, and
87% of head of HHs are farmers. 82% of the houses were
built on stilts compared to 18% built on the ground, the
walls are made of wood (78%) or thatch (21%) and the
roofs are covered with sheets of corrugated iron (61%)
or thatch (32%) (Additional file 1).
Net surveys, net use and washing habits
During 8 field surveys spread over the three study years,
1435 HHs were visited. In the first two years of the study,
more than 80% of the HHs declared to use the net year-
round and every night (Additional file 2). The remaining
20% of the HHs only used their net seasonally, did not use
them or did not provide an answer. No significant dif-
ferences in net use intensity were found after one year
between the three study arms (χ2 test: P = 0.173, df = 12).
After three years the net use intensity dropped to about
60% for both Netprotect® and PermaNet® 2.0. Moreover,
34% of Netprotect® and 20% of PermaNet® 2.0 were recor-
ded as not used anymore and stored away. Those net
users replaced these nets with up-to-that-point unused
spare nets. During the first year 30/601 nets of all three
net types were kept as spare nets. This occurred because
of the over saturation of nets or because most families
slept with more than two individuals under one net. Simi-
larly no significant differences in net use intensity were
found between the two LLINs after three years (χ2 test:
P = 0.213, df = 3).
Out of 522 HHs in which the net to follow up was
present at the end of each year, 250 (48%) HHs recorded
to have washed the net (Additional file 3). For net that
have been washed, the average number of washes per
year reported by the HH for Netprotect and Permanet
2.0 was 3.4 and 3.5 respectively for year one; 1.7 and 2.1for year two, and 1.3 and 2.4 for year three. The accuracy
on the reported washing behaviour is however question-
able as the reported washes declined for the last survey.
Irrespective of the net type, almost all nets were washed
with cold water (98.8%) and with a local detergent or soap
(96%). In 8% of cases the nets were rubbed against rocks.
A total of 65% of the washed nets were dried outside in
the sun, 23% were dried outside in the shade and 10%
were dried inside.
Declared adverse events among the CTN impregnators
and CTN/LLIN users
Both impregnators declared to experience a bad smell
during impregnation, no other adverse events were re-
corded during or after impregnating the nets. Net users
from all study arms declared some adverse events during
the first 6 months of use, while from 12 months post net
distribution and onwards no more adverse events were
declared. The most frequently declared adverse events
were bad smell, itching skin and eye irritation. Analysing
the declared adverse events among the three study arms
within each survey, no significant differences were found
between the three net type users.
Net functional survivorship
The functional survivorship stayed above 90% for both
LLINs in the first two years but after three years this
dropped to about 60% for both Netprotect® (58.1%) and
PermaNet® 2.0 (61.2%) (Table 1).
Physical condition
During the three years of follow up, a total of 507 nets
were sampled and all tested for their physical integrity.
However 42 nets were excluded from analysis, of which 33
had never been used and nine had been thrown away be-
cause being completely torn (one CTN, three Netprotect®
and five PermaNet® 2.0).
The proportion of nets with at least one hole increased
rapidly within the first year up to 89%, 50% and 63% of
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increase continued up to two years of use for both LLINs
to 86%. Finally after three years 83% of Netprotect® and
93% of PermaNet® 2.0 had at least one hole. Similarly the
proportionate hole index (pHI) increased rapidly over
time, but important variation exists between nets for
respectively all net types. Consequently the median
and interquartile range ([IQR] 0.25–0.75) were used
to present the pHI (Figure 1 and Additional file 4).
After one year of use the median pHI was 59 (IQR 8–137)
for CTN, 0.5 (IQR 0–3) for Netprotect® and 3 (IQR 0–27)
for PermaNet® 2.0. After three years, the pHI increased to
68 (IQR 14–186) and 127 (IQR 41–220) for respectively
Netprotect® and PermaNet® 2.0, of which 25% of Netpro-
tect® nets. By the end of the study, the percentage of nets
categorized as in mediocre or poor condition (pHI ≥ 175)
were 25% and 30% for Netprotect® and PermaNet® 2.0, re-
spectively. Over the entire three-year follow-up no signifi-
cant difference was found between both LLIN’s physical
durability (Odds ratio [OR] = 0.82, 95% CI 0.49–1.38 -
GLMM, P = 0.45). Net integrity of both Netprotect® and
PermaNet® 2.0 were affected by the dirtiness, with signifi-
cantly more holes recorded in dirty and very dirty nets
(OR = 39, 95% CI 17–92 - GLMM, P < 0.001 and OR =
122, 95% CI 47–315 - GLMM, P < 0.001, for Netprotect®
and PermaNet® 2.0 respectively).
Chemical content and insecticidal retention
The average active deltamethrin content of each of the
three net types measured one week post distribution was
within the given target dose, though for CTN and
Netprotect® only marginally (Table 2A). Only 14% of the



































Figure 1 Physical condition of individual nets based on the proportio
range (0.25–0.75), dashed line = threshold mediocre/poor net condition (pHdose and this with a high between-net variation (RSD:
78%) showing a low homogeneity of treatment (Figure 2
and Table 2A). Regarding the LLINs, 57% of Netprotect®
nets (RSD: 10%) and 69% of PermaNet® 2.0 nets (RSD:
15%) were within the target dose. The remaining 43% of
Netprotect® nets were below the threshold (Figure 2).
For PermaNet® 2.0 nets, 4% were below the tolerance
limit and 27% were above the maximum allowed delta-
methrin content. After six months of use, all sampled
Netprotect® nets dropped below the initial chemical
target dose while 48% and 33% of PermaNet® 2.0 nets
sampled, respectively after one and three years, were still
within the limits of the initial target dose. Despite this
difference, and taking into account the insecticide con-
tent after one week as baseline, the deltamethrin reten-
tion at 6, and 12 months was similar for the two LLINs
(81% and 62% retention for Netprotect®; 86%, 65% for
PermaNet® 2.0). Though a difference was noted after
three years, 36% retention for Netprotect® and 49% for
PermaNet® 2.0. The CTNs sampled after 12 months of
use retained only 37% of its original content.
Additionally to the content of active S-alpha isomer (del-
tamethrin), the content of the deltamethrin R-alpha inactive
isomer was measured per survey and net type. In the base-
line CTN samples 3% of the deltamethrin content counted
for the R-alpha isomer. This amount remained below 3% in
the samples after six months but did increase to 20% in the
samples collected after one year (Table 2B). For Netprotect®
the deltamethrin R-alpha isomer content in the base-
line samples was 33% of the deltamethrin content; this
high percentage even increased in the samples collected
after 6, 12 and 36 months up to respectively 51%, 53% and
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nate hole index (pHI). Box plot indicating median and interquartile
I ≥175).
Table 2 Chemical analysis
A Average insecticidal residue g/kg (RSD%)
% nets within the tolerance limits of the target dose
N 1 week N 6 months N 1 year N 3 years
CTN 28 0.68 (77.8) 31 0.41 (110.2) 28 0.25 (109.6)
14.3 9.7 14.3
Netprotect® 21 1.38 (10.3) 27 1.12 (10.6) 26 0.88 (18.6) 24 0.49 (51.4)
57.1 0 0 0
PermaNet® 2.0 26 1.61 (15.3) 28 1.37 (22.2) 27 1.05 (43.4) 27 0.83 (49.2)
69.2 82.1 48.1 33.3
B Deltamethrin R-alpha isomer (insecticidally inactive) content, expressed as percentage of the deltamethrin content
(range g/kg)
Survey 1 week 6 month 1 year 3 years
CTN 3% 1% 20%
(<0.01 to 0.05 g/kg) (<0.01 to 0.01 g/kg) (0.01 to 0.39 g/kg)
Netprotect® 33% 51% 53% 69%
(0.35 - 0.54 g/kg) (0.46 - 0.66 g/kg) (0.20 - 0.57 g/kg) (0.09 - 0.55 g/kg)
PermaNet® 2.0 7% 3% 6% 3%
(0.06 to 0.14 g/kg) (0.01 to 0.06 g/kg) (0.03 to 0.09 g/kg) (<0.01 to 0.05 g/kg)
A. Average deltamethrin (S-Isomer) content (in g/kg). The target doses at baseline (tolerance limits of ±25%) are 0.8 (0.6-1) g/kg, 1.8 (1.35 -2.25) g/kg and 1.4
(1.05–1.75) g/kg for CTN, Netprotect® and PermaNet® 2.0 respectively. Between-net variation is expressed by the Relative Standard Deviation (RSD%).
B. Deltamethrin R-alpha isomer content.
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http://www.malariajournal.com/content/13/1/256deltamethrin R-alpha isomer content in the baseline sam-
ples was 7%; this amount remained low in the samples
collected after 6, 12 and 36 months, respectively 3%, 6%
and 3% of the deltamethrin content.
Bio-efficacy
Results from WHO cone bioassays are presented in































1 week 6 Months
Figure 2 Deltamethrin content (S-isomer) on individual sampled nets
limits (±25% of target dose), CTN = conventionally-treated net.4%, this occurred only in two bioassay tests and in
another eight tests control mortality reached 2% while
no mosquito mortality was recorded in all other 451
bioassay tests. The CTNs were fully effective after six
months of use, but both the mosquito knockdown and
mortality rates of CTNs dropped sharply after one year
of use to 56% and 64% respectively. For both LLINs the
average knockdown and mortality were close to 100% upCTN
Netprotect
PermaNet
12 Months 36 Months
over time. Full line = the target dose, dashed lines = the tolerance
Table 3 Cone bioassay results on An. dirus s.s.: Average mosquito knockdown (A) and mosquito mortality rates (B)
A CTN Netprotect® PermaNet® 2.0
N KD% (a) N KD% (a) N KD% (a)
b b b
1 Week 28 74.2 (28.7) 21 92.6 (14.5) 26 95.3 (10.4)
13.2 5.3 4.3
6 Months 31 97.5 (8.0) 27 99.8 (1.9) 28 100
2.1 0.3
12 Months 28 56.3 (47.0) 26 84.4 (26.5) 27 88.4 (24.4)
13.4 9.3 5.6
18 Months 29 91.8 (14.4) 27 93.5 (13.0)
6.3 6.2
24 Months 29 78.8 (19.4) 30 85.7 (18.9)
11.9 10.8
30 Months 25 85.0 (20.4) 28 86.5 (18.3)
7.7 7.6
36 Months 24 81.7 (20.3) 27 87.2 (15.5)
9.2 8.8
B CTN Netprotect® PermaNet® 2.0
N Mortality% (a) N Mortality% (a) N Mortality% (a)
b b b
1 Week 28 81.5 (24.2) 21 98.2 (6.6) 26 99.2 (3.9)
10.1 2.0 1.1
6 Months 31 97.3 (7.8) 27 99.5 (3.0) 28 100
2.6 0.8
12 Months 28 64.1 (48.4) 26 85.7 (23.3) 27 91.3 (18.1)
12.5 9.5 6.0
18 Months 29 89.7 (17.6) 27 92.1 (17.1)
8.2 7.6
24 Months 29 84.1 (22.9) 30 92.1 (13.4)
9.4 6.8
30 Months 25 89.3 (16.3) 28 90.8 (14.9)
6.5 6.2
36 Months 24 82.9 (25.0) 27 88.6 (15.2)
9.6 8.9
CTN = conventionally-treated net, KD = knockdown, a = between net relative standard deviation (%), b = within-net variability (%).
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http://www.malariajournal.com/content/13/1/256to six months of use. After 12 months a small drop of
about 10% for both knockdown and mortality rates was
recorded. Despite this small drop and the constant loss
of deltamethrin over time, these average rates were
maintained up to three years with an average mortality
and knockdown around or above 80%. Both LLINs
performed significantly better than the CTNs after one
year of use (GLMM mosquito mortality, P < 0.001) while
after three years both LLIN average mortality rates did
not differ (GLMM, P = 0.17). However when mortality
rates over the entire three years are compared, PermaNet®2.0 does obtain significantly higher mosquito mortality
than Netprotect® (GLMM, P = 0.023). For each net type a
multivariate analysis was carried out (GLMM) to assess
the relative role of net use intensity, washing, net condi-
tion, dirtiness, chemical content and time of observation
on the bio-efficacy of each net type. Time of observation
showed a significant association with the bio-efficacy of all
three net types (GLMM, P = 0.01, P < 0.001 and P = 0.006
respectively for CTN, Netprotect® and PermaNet® 2.0).
CTN bio-efficacy was negatively correlated with bad net
condition (GLMM, P = 0.03) and its chemical content
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number of washes, washing methods and the chemical
content was not correlated to their corresponding
bio-efficacy. For both Netprotect® and PermaNet® 2.0,
the between- and within-net variations of knockdown and
mortality follow similar trends (Table 3).
The seven Netprotect® and four PermaNet® 2.0 nets
that failed the bioassay criteria after 36 months were
subjected to the tunnel test. All tunnel tests were valid,
with an mortality in the control of less than 6% and
more than 76% were blood fed. None of the tested nets
passed the tunnel test criteria of 80% mortality or 90%
blood feeding inhibition (see Additional file 5).
The proportions of LLINs that fulfil the WHO criteria
(≥95% knockdown or ≥80% mortality) are reported in
Table 4. Only 42% of the CTNs complied with these
criteria after one year of use, while 73% and 85% of
Netprotect® and PermaNet® 2.0 did. The proportion of
Netprotect® nets that met the efficacy criteria varied
throughout the study and was below the WHOPES thresh-
old of 80% after 12, 24 and 36 months (respectively 73, 72
and 71%), however the 80% value was still within the confi-
dence intervals. Whereas PermaNet® 2.0 performance was
consistent over the entire three study years with a success
rate of more than 80%. The acceptance of nets is entirely
based on nets complying with the mortality criteria, as
there are no nets that pass the 95% knockdown rate and
then fail the 80% mortality rate. The acceptance over theTable 4 Percentage of nets meeting WHOPES criteria
(knockdown ≥ 95% or mortality ≥ 80%) according to cone
tests
CTN Netprotect® PermaNet® 2.0
N % N % N %
95% CI 95% CI 95% CI
1 Week 28 60.7 21 100 26 100
42.4 - 76.4 84.5 - 100 87.1 - 100
6 Months 31 100 27 100 28 100
89 - 100 87.5 - 100 87.9 - 100
12 Months 28 42.9 26 73.1 27 85.2
26.5 - 60.9 53.9 – 86.3 67.5 - 94.1
18 Months 29 89.7 27 92.6
73.6 – 96.4 76.6 – 97.9
24 Months 29 72.4 30 93.3
54.3 – 85.3 78.7 – 98.2
30 Months 25 88.0 28 85.7
70 – 95.8 68.5 – 94.3
36 Months 24 70.8 27 85.2
50.8 – 85.1 67.5 – 94.1
CTN = conventionally-treated net, CI = confidence interval.
After 36 months none the nets tested for the tunnel tests fulfil the WHOPES
criteria.period of one to three years was significantly higher
for the reference LLIN than for Netprotect® (Mantel-
Haenszel Test: OR = 2.091 [95% CI 1.071 – 4.083]; p =
0.0044).
Discussion
This study evaluated the performance of Netprotect®, an
interim recommended LLIN, using a WHOPES recom-
mended LLIN, PermaNet® 2.0 as positive control, for
three years under daily household use. A candidate net
will be deemed to meet the requirements for an LLIN if,
at the end of three years use, at least 80% of the sampled
nets retain bio-efficacy (i.e. ≥95% mosquito knockdown
rate or ≥80% mortality) with a standard WHO cone bio-
assay or with a tunnel test (≥80% mortality or ≥90% blood
feeding inhibition) [7]. Following these criteria Netprotect®
failed in the present phase III prospective study (71% of
nets are effective after three years) and the LLIN status of
PermaNet® 2.0 (85% of nets are effective after three years)
was confirmed. Moreover Netprotect® failed for the bioas-
says criteria after already 12 and after 24 months (73%
and 72% respectively of nets being effective).
However, the 95% confidence interval of the success
rate for Netprotect® after three years is rather large
(51-95%) and it still includes the 80% threshold. In the
future, a more accurate estimate could be obtained by
sampling more nets after three years of use. The new
guidelines recommend sampling 50 nets after three years
(instead of 30) [25] but this may still not be enough. How-
ever, throughout the three years the effectiveness of
Netprotect® showed less consistency as compared to
PermaNet® 2.0. Moreover over the entire observation
period Netprotect® had a significant lower bio-efficacy
as compared to PermaNet® 2.0. In terms of physical dur-
ability, Netprotect® performed as well as PermaNet® 2.0.
The marginal bio-efficacy performance of Netprotect®
is probably related to the low insecticide content. At the
baseline of the study already 43% of Netprotect® nets
had a deltamethrin content below the target dose while
PermaNet® 2.0 started with 27% of nets above their tar-
get dose showing that also recommended brands are
outside of WHO specifications. The lower initial insecti-
cide content for Netprotect® was probably a consequence
of a problem in the manufacturing process as shown by
a high proportion of the inactive R-alpha isomer (33%)
relative to the deltamethrin content. Moreover, the pro-
portion of the inactive R-alpha isomer, and so the isomeri-
zation, continued to increase throughout the study to up to
69% of deltamethrin content. As opposed to Netprotect®,
PermaNet® 2.0 inactive deltamethrin R-alpha isomer re-
mains almost constant during the 36 months of obser-
vation (3 to 7%).
In a similar phase III follow-up study of Netprotect®
in Ghana [26], Netprotect® also failed the WHOPES
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after 18 months insufficient Netprotect® nets (63%) met
the criteria. The bio-efficacy of Netprotect® showed also
more inconsistency: after two years only 43% of Netprotect®
nets passed the cone bioassay criteria while after 2.5 and
3 years respectively 64% and 62% (95% CI 48–74) did.
Correspondingly in Ghana the average deltamethrin con-
tent of the Netprotect® nets at the baseline were at the
lower limit of the specifications and with high amounts of
the R-alpha isomer (30%). Cumulating the bioassay re-
sults of the sampled three-year old Netprotect® nets
from both phase III studies in Ghana and Cambodia,
only 64.9% (95% CI 54–75) of nets met the WHOPES
criteria for a LLIN.
Based on different studies the 16th WHOPES working
group meeting [26] recommended that until more evi-
dence of Netprotect® is available from large scale studies,
the WHO interim recommendation should be withdrawn
and invite the national programs currently using Netprotect®
to monitor efficacy and performance of this brand
under local conditions [4]. Indeed, 80% of the nets did not
fulfil the WHO criteria for bioassays after 3 years of use as
prescribed in the Guidelines [7] applied for this evaluation.
Moreover the specifications for the chemical content were
not met.
The use of a fully recommended LLIN as positive control
was shown to be extremely useful for validating the results
of the study and is now being part of the new WHOPES
guidelines [25]. However, before starting such three-year
studies it would be essential that nets are checked for their
compliance with WHO specifications and this for the can-
didate LLIN as well as for the reference net. This has now
been adapted by the new WHOPES guidelines [25]. It
would also be recommended to use confidence intervals
for the proportion of nets meeting the WHO criteria for
bioassays and to define a statistical approach for reviewing
the bio-efficacy of LLINs over time.Additional files
Additional file 1: Household characteristics.
Additional file 2: Net use intensity. The table shows the study
participants declared net use intensity per survey and per study arm.
Additional file 3: Washing frequency. The table shows the proportion
of nets washed and the average frequency of washing per year.
Additional file 4: Physical condition of nets. The table shows the
average, median and interquartile range of the proportionate Hole Index
of all three study arms and per survey. Proportion of nets in mediocre
and poor condition is given.
Additional file 5: Tunnel test results on An. dirus s.s.: Average
mosquito mortality rates and blood-feeding inhibition.Competing interests
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